Currently there are a dozen or so of new vaccine candidates in clinical trials for prevention of tuberculosis (TB) and each formulation attempts to elicit protection by enhancement of cell-mediated immunity (CMI). In contrast. most approved vaccines against other bacterial pathogens are believed to mediate protection by eliciting antibody responses. However. https://www.protectoracarballo.com/product-category/feature/